MENU
+Compare
AZN
Stock ticker: NASDAQ
AS OF
Aug 29 closing price
Price
$79.90
Change
-$0.09 (-0.11%)
Capitalization
247.21B

AZN AstraZeneca PLC Forecast, Technical & Fundamental Analysis

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999... Show more

AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AZN with price predictions
Aug 29, 2025

AZN in upward trend: 10-day moving average moved above 50-day moving average on July 29, 2025

The 10-day moving average for AZN crossed bullishly above the 50-day moving average on July 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AZN advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 283 cases where AZN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AZN moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where AZN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AZN turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AZN broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.540) is normal, around the industry mean (9.442). P/E Ratio (30.094) is within average values for comparable stocks, (23.820). Projected Growth (PEG Ratio) (1.017) is also within normal values, averaging (1.846). Dividend Yield (0.020) settles around the average of (0.027) among similar stocks. P/S Ratio (4.421) is also within normal values, averaging (3.417).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AZN is expected to report earnings to fall 47.47% to $1.14 per share on November 06

AstraZeneca PLC AZN Stock Earnings Reports
Q3'25
Est.
$1.14
Q2'25
Beat
by $1.08
Q1'25
Beat
by $1.39
Q4'24
Beat
by $1.03
Q3'24
Beat
by $1.06
The last earnings report on July 29 showed earnings per share of $2.17, beating the estimate of $1.09. With 2.82M shares outstanding, the current market capitalization sits at 247.21B.
A.I.Advisor
published Dividends

AZN is expected to pay dividends on September 08, 2025

AstraZeneca PLC AZN Stock Dividends
A dividend of $0.51 per share will be paid with a record date of September 08, 2025, and an ex-dividend date of August 08, 2025. The last dividend of $1.05 was paid on March 24. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
89900
Web
https://www.astrazeneca.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NIE24.830.04
+0.16%
Virtus Equity & Convertible Income Fund
PSCQ28.66N/A
N/A
Pacer Swan SOS Conservative (Oct) ETF
APMU24.93-0.01
-0.05%
ActivePassive Intermediate Mcpl Bd ETF
FBND45.88-0.05
-0.11%
Fidelity Total Bond ETF
BPH54.63-0.19
-0.35%
BP PLC ADRHEDGED BPH

AZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.11%
GSK - AZN
63%
Loosely correlated
+0.58%
NVS - AZN
61%
Loosely correlated
+0.06%
SNY - AZN
50%
Loosely correlated
-0.92%
AZNCF - AZN
48%
Loosely correlated
+1.85%
PFE - AZN
47%
Loosely correlated
+0.65%
More